Plus Therapeutics, Inc.
LIPOSOMAL TAXANES FOR TREATMENT OF SCLC

Abstract:

Methods for therapy for a small cell lung cancer (SCLC), which may or may not respond to a first-line therapy or that progresses following cessation of a first-line chemotherapy is provided. Some methods include the administration of composition that comprises a protein-stabilized form of docetaxel, optionally in conjunction with a regimen of supportive care.